Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.jconrel.2011.11.002
Title: In vivo efficacy of a novel liposomal formulation of safingol in the treatment of acute myeloid leukemia
Authors: Tan, K.-B.
Ling, L.-U.
Bunte, R.M. 
Chng, W.-J.
Chiu, G.N.C. 
Keywords: Acute myeloid leukemia
Hemolysis
Liposome
Safingol
Sphingolipid
Zeta potential
Issue Date: 10-Jun-2012
Source: Tan, K.-B., Ling, L.-U., Bunte, R.M., Chng, W.-J., Chiu, G.N.C. (2012-06-10). In vivo efficacy of a novel liposomal formulation of safingol in the treatment of acute myeloid leukemia. Journal of Controlled Release 160 (2) : 290-298. ScholarBank@NUS Repository. https://doi.org/10.1016/j.jconrel.2011.11.002
Abstract: Prognosis of patients with acute myeloid leukemia (AML) remains poor despite the use of first-line induction chemotherapy. Therefore, it is imperative to find effective treatment for AML patients. Safingol is a bioactive sphingolipid which has demonstrated promising in vitro anti-leukemic properties; however, translation into clinical use is hampered by its low water solubility and dose-limiting hemolysis. The present study is the first to describe a rationally designed liposome formulation of safingol and demonstrate the anti-leukemic potential using a panel of human AML cell lines and patient samples as well as a human xenograft model in SCID mice. Encapsulation efficiency of safingol into liposomes was approximately 100%, and the release of drug followed square-root-of-time release model. The presence of a transmembrane pH gradient completely abolished the biological activity of liposomal safingol. A positive zeta potential, which influenced cellular accumulation of liposomal safingol, was crucial to the anti-leukemic activity. Liposomal safingol was effective against a wide range of AML subtypes with minimal hemolytic toxicity, and was able to extend the median survival time of the U937-inoculated mice to 31 days as compared to 23 days by free drug. The increase in therapeutic efficacy could be related to the increase in systemic drug exposure as a result of liposome encapsulation. © 2011 Elsevier B.V.
Source Title: Journal of Controlled Release
URI: http://scholarbank.nus.edu.sg/handle/10635/52988
ISSN: 01683659
DOI: 10.1016/j.jconrel.2011.11.002
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

17
checked on Dec 13, 2017

WEB OF SCIENCETM
Citations

13
checked on Nov 14, 2017

Page view(s)

52
checked on Dec 16, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.